丹納赫收購NobelBiocare控制其97％股票

　　2014年12月11日，丹納赫宣布即將完成收購Nobel Biocare公司目前公開發行的股票。附加承諾期已于2014年12月4日到期。

　　丹納赫現在已控制Nobel Biocare大約97%的股票。

　　2015年第一季度，丹納赫計劃要求注銷Nobel Biocare未完成的公眾持有記名股票。此外，丹納赫可能決定將Nobel Biocare排除合并為丹納赫所掌控的公司。無論哪種方案下，丹納赫預計余下的股東將獲得每股不超過17.1的瑞士法郎（這是公開要約支付價格）。

　　由于瑞士最優惠價格規則，附加承諾期（2014年12月4日）的到期后六個月內繼續申請，丹納赫可以不支付超過每股17.10瑞士法郎的Nobel Biocare在公開市場以其他方式購買的任何股份。

　　此外，丹納赫計劃將Nobel Biocare將從瑞士證券交易所退市。

Danaher Completes Acquisition Of Nobel Biocare

　　WASHINGTON, Dec. 11, 2014 /PRNewswire/  --Danaher Corporation (DHR) announces that today it will settle the public tender offer for all the registered shares of Nobel Biocare Holding AG ("Nobel Biocare").The additional acceptance period for the tender offer expired on December 4, 2014.

　　Danaher now controls approximately 97% of the issued registered shares of Nobel Biocare.

　　Sometime in the first quarter of 2015, Danaher intends to request the cancellation of the outstanding publicly held registered shares of Nobel Biocare. Alternatively, Danaher may decide to initiate a squeeze-out merger of Nobel Biocare into a company controlled by Danaher. In either such squeeze-out case, Danaher anticipates that the remaining shareholders will receive no more than CHF 17.10 per share (which is the consideration paid in the public tender offer).

　　Due to the Swiss best price rule that continues to apply during the six months following the end of the additional acceptance period (December 4, 2014) of the public tender offer, Danaher may not pay more than CHF 17.10 per share for any remaining shares of Nobel Biocare purchased in the open market or otherwise.

　　Furthermore, Danaher intends to have Nobel Biocare apply with SIX Swiss Exchange ("SIX") for the de-listing of the registered shares of Nobel Biocare in accordance with the listing rules of SIX and for an exemption of certain disclosure obligations under the listing rules of SIX until the date of de-listing of the registered shares of Nobel Biocare.

　　About Danaher

　　Danaher is a global science and technology innovator committed to helping its customers solve complex challenges and improving quality of life around the world. Its family of world class brands have unparalleled leadership positions in some of the most demanding and attractive industries, including health care, environmental and industrial. The company's globally diverse team of 66,000 associates is united by a common culture and operating system, the Danaher Business System. In 2013, Danaher generated $19.1 billion in revenue and its market capitalization exceeded $50 billion. For more information please visit

　　www.danaher.com.